The prevention and treatment of cytomegalovirus infection in haematopoietic stem cell transplantation

被引：0
|
作者：
Mark Tuthill
Frederick Chen
Samantha Paston
Hugo De La Peña
Sylvie Rusakiewicz
Alejandro Madrigal
机构：
[1] The Anthony Nolan Research Institute,
[2] Royal Free Hospital,undefined
来源：
Cancer Immunology, Immunotherapy | 2009年 / 58卷
关键词：
CMV; Vaccine; Adoptive cellular therapy; Artificial antigen presenting cells;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Allogeneic haematopoietic stem cell transplantation (HSCT) is an intensive medical treatment involving myeloablative chemo-radiotherapy followed by stem cell rescue using allogeneic haematopoietic stem cells harvested from HLA-matched donors, which is primarily used for the treatment of haematological malignancies. Cytomegalovirus (CMV) infection is one of the major causes of morbidity and death after HSCT. This focused research review highlights the advances made with research into CMV in the HSCT setting. It provides the reader with an overview of current CMV research into the prevention and management of CMV infection.
引用
收藏
页码：1481 / 1488
页数：7
相关论文
共 50 条
  • [31] Cytomegalovirus infection after allogeneic haematopoetic stem cell transplantation
    Ovsjannikova, M.
    Semenova, E.
    Stancheva, N.
    Zubarovskaya, N.
    Antonova, T.
    Pankratova, O.
    Afanasyev, B.
    [J]. BONE MARROW TRANSPLANTATION, 2007, 39 : S175 - S175
  • [32] Cytomegalovirus infection/disease after hematopoietic stem cell transplantation
    Mori, Takehiko
    Kato, Jun
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 91 (04) : 588 - 595
  • [33] Cytomegalovirus infection/disease after hematopoietic stem cell transplantation
    Takehiko Mori
    Jun Kato
    [J]. International Journal of Hematology, 2010, 91 : 588 - 595
  • [34] Cytomegalovirus infection after allogeneic haemopoetic stem cell transplantation
    Ovsjannikova, M
    Emeljanova, S
    Vinogradskaja, G
    Stancheva, N
    Semenova, E
    Zubarovskaya, L
    Afanasjev, B
    [J]. BONE MARROW TRANSPLANTATION, 2006, 37 : S177 - S177
  • [35] Is cytomegalovirus a risk factor for haemorrhagic cystitis in allogeneic haematopoietic stem cell transplantation recipients?
    Atilla, Erden
    Yalciner, Merih
    Ailla, Pinar Ataca
    Ates, Can
    Bozdag, Sinem Civriz
    Yuksel, Meltem Kurt
    Toprak, Selami Kocak
    Gunduz, Mehmet
    Ozen, Mehmet
    Akan, Hamdi
    Demirer, Taner
    Arslan, Onder
    Ilhan, Osman
    Beksac, Meral
    Ozcan, Muhit
    Gurman, Gunhan
    Topcuoglu, Pervin
    [J]. ANTIVIRAL THERAPY, 2018, 23 (08) : 647 - 653
  • [36] Thrombotic Microangiopathy in Haematopoietic Stem Cell Transplantation Diagnosis and Treatment
    Choi, Cecilia M.
    Schmaier, Alvin H.
    Snell, Michael R.
    Lazarus, Hillard M.
    [J]. DRUGS, 2009, 69 (02) : 183 - 198
  • [37] Autologous haematopoietic stem cell transplantation for the treatment of multiple sclerosis
    Loh, Yvonne S. M.
    Hwang, William Y. K.
    Ratnagopal, Pavanni
    [J]. ANNALS ACADEMY OF MEDICINE SINGAPORE, 2007, 36 (06) : 421 - 426
  • [38] Treatment of malignant infantile osteopetrosis with haematopoietic stem cell transplantation
    Hamidieh, A.
    Behfar, M.
    Hosseini, A.
    Aliabadi, L. Sharifi
    Basirpanah, S.
    Ghavamzadeh, A.
    [J]. BONE MARROW TRANSPLANTATION, 2013, 48 : S51 - S51
  • [39] Clinical analysis of the usefulness of letermovir for prevention of cytomegalovirus infection after haploidentical hematopoietic stem cell transplantation
    马瑞
    [J]. China Medical Abstracts (Internal Medicine), 2023, 40 (04) : 232 - 232
  • [40] Prevention of Cytomegalovirus Infection after Hematopoietic Stem Cell Transplantation: Preemptive Therapy Vs Universal Prophylaxis
    Mossad, S.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : E329 - E329
12345